Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
- Citation:
- Blood Cancer J vol 12 (4)
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Pharmas:
- Janssen Oncology
- Grants:
- Corr. Author:
- Authors:
- Ajay K. Nooka Jonathan L. Kaufman Cesar Rodriguez Andrzej Jakubowiak Yvonne Efebera Brandi Reeves Tanya Wildes Sarah A. Holstein Larry D. Anderson Jr Ashraf Badros Leyla Shune Ajai Chari Huiling Pei Annelore Cortoos Sharmila Patel J. Blake Bartlett Jessica Vermeulen Thomas S. Lin Paul G. Richardson Peter Voorhees
- Networks:
- KANSAS, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-OH007, LAPS-TX011, MD015, NC002, NE003, OH008
- Study
- AFT-29 (GRIFFIN)
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: